Mycophenolate mofetil versus cyclosporin A in high risk keratoplasty patients: a prospectively randomised clinical trial

BACKGROUND/AIMS—The requirement for an effective, minimally toxic immunosuppressive agent remains a major obstacle to performing high risk corneal transplantation. Although therapy with cyclosporin A (CSA) allows superior graft survival, its use is limited because of a wide range of side effects. My...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Reis, A., Reinhard, T., Voiculescu, A., Kutkuhn, B., Godehardt, E., Spelsberg, H., Althaus, C., Sundmacher, R.
Formato: Artigo
Idioma:Inglês
Publicado em: 1999
Assuntos:
Original articles - Clinical science
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1722847/
https://ncbi.nlm.nih.gov/pubmed/10535855
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados